Medical Director, Clinical Development
Job Description
Key Skills Required
Master these to land this role
Want to know if you're a match for this job?
At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team-oriented culture, we are working together to advance Kailera’s mission to advance novel therapies for obesity and related conditions.
We are passionate about creating an inclusive workplace that promotes collaboration, integrity, and excellence. As we expand, we seek the most talented individuals with diverse backgrounds, cultures, perspectives, and experiences to join our team.
What You’ll Do:
We are seeking an experienced, highly motivated Medical Director, Clinical Development to join our growing team. This individual will play a pivotal role in designing and executing clinical development programs that advance our pipeline of innovative therapeutics. The successful candidate will bring strong clinical insight, a deep understanding of drug development in a biotech setting, and a proven ability to work cross-functionally in a dynamic, fast-paced environment.
Required location: Waltham, MA (hub-based, onsite 3-4 days per week) OR Remote (home-based, onsite at a hub 1 week every other month).
Responsibilities:
- Responsible for medical monitoring/reporting and safety activities
- Provide medical leadership in the design, planning, and execution of clinical development strategies across multiple studies
- Acts as the medical contact at the company for clinical/medical issues
- Interprets, reports, and prepares oral and written results of product research, in concert with senior clinical personnel
- Serve as the medical expert for assigned assets studies
- Contribute to regulatory interactions and strategy, such as IND/CTA/NDA submissions and briefing packages
- Collaborate and work closely with Clinical Operations to ensure appropriate site selection, patient recruitment strategies, and high-quality trial execution
- Oversee and support data interpretation, analysis, and clinical study reports
- Work closely with internal stakeholders, including Regulatory, Safety, CMC, and Translational Science teams
- Partner with external collaborators, KOLs, CROs, and investigators
- Support scientific publications, conference presentations, and other external communications
- Participate in safety review meetings and provide clinical input into adverse event evaluation and reporting
Required Qualifications:
- 2+ years of industry experience in clinical development, preferably in a biotech or small pharma environment
- Hands-on experience designing and executing clinical trials
- Experience with regulatory submissions and global regulatory filings
- Understanding of GCP, clinical trial design, regulatory requirements, and safety monitoring
- Excellent written and verbal communication skills, including protocol and regulatory document writing
- Demonstrated ability to engage with KOLs, investigators, and cross-functional teams
- Can work independently, self-starter attitude
Preferred Qualifications:
- Experience across multiple therapeutic areas, including obesity, is advantageous
- Proven track record of contributing to BLA/NDA submissions is a strong plus
Education:
- MD or equivalent is required
How would you rate this job post?
See what other professionals think about this role.
Similar Opportunities
Talent Acquisition Specialist
Charger logistics Inc.
United StatesPeople Operations Specialist & Senior People Operations Manager
Valiantys
United StatesDirector of Company Operations - West Division
Empower Brands
United StatesDirector of Company Operations - East Division
Empower Brands
United StatesMore Openings at Kailera Therapeutics
Explore Top Companies in this Space
Vera Therapeutics
Biotechnology / Pharmaceuticals & Biotech
Rockstar
Staffing & Recruiting / AI / Human Resources / SaaS
blackstoneeit.com
Not specified
Civiteq
IT Consulting / Public Sector / Digital Transformation / ERP
Kailera Therapeutics
View Company ProfileKailera Therapeutics is the premier, enterprise-grade clinical-stage biotechnology pioneer, multi-receptor incretin therapy innovator, and metabolic healthcare powerhouse engineered to operate as the definitive, high-velocity developer layer for next-generation obesity and cardiometabolic disease treatments globally. The company completely eliminates the severe systemic friction of modern weight-management therapeutics—where first-generation single-receptor treatments face commercial efficacy ceilings, plateaus in total body weight loss, injection delivery barriers, and challenging gastrointestinal side effects—by deploying an advanced, multi-pronged incretin and small-molecule discovery platform. Moving far beyond traditional, passive disease research models or isolated chemical formulation screening, Kailera natively unifies once-weekly injectable dual-agonist peptides (ribupatide/KAI-9531 targeting GLP-1 and GIP), highly differentiated once-daily oral small-molecule alternatives, and next-generation triple-agonist (triple-G) programs (KAI-4729 targeting GLP-1, GIP, and glucagon receptors) into a unified, high-conviction clinical portfolio. Launched via a record-shattering $625 million initial public offering (IPO) on the Nasdaq Stock Market (NASDAQ: KLRA) that bypassed typical early biotech capital constraints, the firm maintains an expansive financial run-rate to advance its broad global Phase 2b and Phase 3 KaiNETIC clinical development tracks with production-hardened scientific precision. Under the hood, its sophisticated technical practice leverages exclusive ex-China asset licenses from global pharmaceutical giant Jiangsu Hengrui, running automated high-throughput data pipelines, rigorous multi-tenant patient trial monitoring frameworks, and strict FDA and global health authority compliance structures. What sets Kailera Therapeutics apart is its uncompromising dedication to replacing mechanical treatment protocols with absolute therapeutic options and long-term metabolic health momentum; by bridging the gap between performance-intensive big data receptor analytics and convenient, highly tolerable patient-centric treatments, the institution remains the definitive, category-defining cornerstone of modern incremental weight loss and metabolic clinical innovation.
Safety First
- Never pay for a job application.
- Do not share sensitive bank info.
- Verify the client before starting work.